A Phase IIa Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication.

Trial Profile

A Phase IIa Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Mar 2012

At a glance

  • Drugs Cilostazol; K 134
  • Indications Embolism and thrombosis; Intermittent claudication
  • Focus Therapeutic Use
  • Most Recent Events

    • 21 Mar 2012 Actual patient number is 387 according to ClinicalTrials.gov.
    • 10 Nov 2011 Results were reported at the American Heart Association Scientific Sessions, according to a Kowa media release.
    • 01 Jul 2010 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top